EYPT EyePoint Pharmaceuticals, Inc.
$13.41
▲ 0.45%
29
Value
14
P/E-4.25
8
P/B5.00
45
P/S147.56
0
EV/EBITDA-3.83
5
Growth
24
Revenue Growth-27.5%
0
EPS Growth-36.6%
41
FCF Growth-86.8%
34
Momentum
70
12-Month Return114.6%
100
3-Month Return5.3%
69
1-Month Return-5.4%
44
RSI (14)31.73
50
50/200 MABullish
75
Profitability
16
ROE-110.5%
30
ROA-94.2%
0
Gross Margin76.5%
63
Operating Margin-3700.9%
0
Net Margin-3566.6%
0
FCF Yield-21.7%
0
Risk
16
Beta1.77
35
60-Day Volatility67.1%
0
QScore Analysis